Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy;Aspetti socio-demografici e modalità di accesso alle terapie farmacologiche in pazienti con artrite reumatoide in Italia

Reumatismo

Volumn 61, Issue 3, 2009, Pages 197-211

  Salaffi, Fausto ^a   Vaccaro, C M ^b   Manacorda, T ^b   Pardini, L ^b   Montecucco, C M ^c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Centro Studi Investimenti Sociali (CENSIS)   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACCESS TO INFORMATION; ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; EARLY DIAGNOSIS; FEMALE; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL SPECIALIST; PATIENT ATTITUDE; PATIENT REFERRAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SELF EVALUATION; SOCIAL STATUS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DEMOGRAPHY; DISABILITY EVALUATION; DRUG THERAPY, COMBINATION; FAMILY CHARACTERISTICS; FEMALE; GLUCOCORTICOIDS; HUMANS; ITALY; MALE; MIDDLE AGED; OCCUPATIONS; PHYSICAL THERAPY MODALITIES; QUESTIONNAIRES; RISK FACTORS; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 70449504179     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bulletin World Health Organization 2003; 81: 646-656
2. Centers for Disease Control and Prevention. Health-related quality of life among adults with arthritis-Behavioral Risk Factor Surveillance System, 11 states, 1996-1998. Morb Mortality Wkly Rep 2000; 49: 366-369
3. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009; 18: 7-25.
4. Salaffi F, De Angelis R, Stancati A, Grassi W; MArche Pain; Prevalence INvestigation Group (MAPPING) study. Health-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING study. Clin Exp Rheumatol 2005; 23: 829-839
5. Salaffi F, De Angelis R, Grassi W; MArche Pain Prevalence; Investigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol 2005; 23: 819-828
6. Cimmino Ma, Parisi M, Moggiana Gl, Maio T, Mela GS. Prevalence of self-reported peripheral joint pain and swelling in an Italian population: the Chiavari study. Clin Exp Rheumatol 2001; 19: 35-40. (Pubitemid 32203844)
7. Andrianakos A, Trontzas P, Christoyannis F, et al. Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG study. J Rheumatol 2003; 30: 1589-1601 (Pubitemid 36835462)
8. Carmona L, Ballina J, Gabriel R, Laffon A, on behalf of the EPISER Study Group. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 2001; 60: 1040-1045
9. Aho K, Kaipiainen O, Heliövaara M, Klaukka T. Epidemiology of rheumatoid arthritis in Finland. Semin Arthritis Rheum 1998; 27: 325-334
10. Steven MM. Prevalence of chronic arthritis in four geographic areas of the Scottish Highlands. Ann Rheum Dis 1992; 51: 186-194
11. Stojanovic R, Vlajinac H, Palic-Obradovic D, Janosevic S, Adanja B. Prevalence of rheumatoid arthritis in Belgrade, Yugoslavia. Br J Rheumatol 1998; 37: 729-732 (Pubitemid 28370664)
12. Macgregor AJ, Riste LK, Hazes JM, Silman AJ. Low prevalence of rheumatoid arthritis in black-caribbeans compared with whites in inner city Manchester. Ann Rheum Dis 1994; 53: 293-297
13. Kvien TK, Glennas A, Knudsrod Og, Smedstad LM, Mowinckel P, Forre O. The prevalence and severity of rheumatoid arthritis in Oslo. Result from a county register and a population survey. Scand J Rheumatol 1997; 26: 412-418 (Pubitemid 28005043)
14. Akar S, Birlik M, Gurler O, et al. The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 2004; 22: 416-420 (Pubitemid 39089801)
15. Rodriguez Senna E, De Barros ALP, et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004; 31: 594-597
16. Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P. Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. J Rheumatol 1998; 25: 1382-1387 (Pubitemid 28312359)
17. Dans LF, Tankeh-Torres S, Amante CM, Penserga EG. The prevalence of rheumatic diseases in a Filipino urban population: A WHO-ILAR COPCORD study. J Rheumatol 1997; 24: 1814-1819
18. Silman AJ, Hochberg MC. Epidemiology of the rheumatic diseases. Oxford: Oxford University Press; 1993.
19. Dugowson CE, Koepsell TD, Voigt Lf, Bley L, Nelson Jl, Daling JR. Rheumatoid arthritis in women: incidence rates in Group Health Cooperative, Seattle, Washington, 1987-1989. Arthritis Rheum 1991; 34: 1502-1507
20. Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpä ä S, Leirisalo-Repo M, et al; FINRACo Trial Group. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Arthritis Rheum 2009; 29: 1222-1231
21. Schoels M, Aletaha D, Smolen JS, Bijlsma JW, Burmester GR, Breedveld FC, et al. Follow-up standards and treatment targets in Rheumatoid Arthritis (RA): Results of a questionnaire at the EULAR 2008. Ann Rheum Dis 2009 [Epub ahead of print].
22. Marchesoni A, Govoni M, Valentini G, Valesini G, Salaffi F, Macchioni P, et al. The Italian registry of aggressive rheumatoid arthritis - the GIARA project. J Rheumatol 2007; 34: 2374-2381 (Pubitemid 350230658)
23. Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 2006;10: 1-229. (Pubitemid 44910057)
24. Doan QV, Chiou CF, Dubois RW. Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis. J Manag Care Pharm 2006; 12: 555-569
25. Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A. Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety. BMC Musculoskelet Disord 2008; 17; 9: 52. (Pubitemid 351678129)
26. Caporali R, Caprioli M, Bobbio-Pallavicini F, Bugatti S, Montecucco C. Long term treatment of rheumatoid arthritis with rituximab. Autoimmun Rev 2009; 8: 591-594
27. Mancarella L, Bobbio-Pallavicini F, Ceccarelli F, Falappone PC, Ferrante A, Malesci D, et al. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol 2007; 34: 1670-1673 (Pubitemid 47267608)
28. Filippucci E, Iagnocco A, Salaffi F, Cerioni A, Valesini G, Grassi W. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis 2006; 65: 1 433-437 (Pubitemid 44629118)
29. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324
30. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003; 49: 156-63.32. (Pubitemid 36418272)
31. Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995; 38: 795-798
32. Veehof MM, ten Klooster PM, Taal E, van Riel PLCM,van de Laar MAFJ. Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting antitumour necrosis factor treatment. Ann Rheum Dis 2008; 67; 789-793
33. Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol 1999; 26: 2475-2479